The Impact of Smoking on Post-Clopidogrel Platelet Reactivity in Patients With Acute Myocardial Infarction

Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined. S...

Full description

Saved in:
Bibliographic Details
Published inKorean circulation journal Vol. 40; no. 3; pp. 119 - 124
Main Authors Cho, Jung-Hyun, Jeong, Young-Hoon, Ahn, Yeon-Jeong, Kang, Min-Kyung, Koh, Jin-Sin, Kim, In-Suk, Park, Yongwhi, Hwang, Seok-Jae, Kwak, Choong Hwan, Hwang, Jin-Yong
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society of Cardiology 01.03.2010
대한심장학회
Subjects
Online AccessGet full text
ISSN1738-5520
1738-5555
1738-5555
DOI10.4070/kcj.2010.40.3.119

Cover

Abstract Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined. Study cohorts were recruited from a pool of patients at our hospital who were undergoing coronary stenting for AMI (n=134). Immediately after arrival at the emergency room (ER), all patients received a 600 mg loading dose of clopidogrel followed by a maintenance dose of 75 mg/day. Platelet aggregation was measured with light transmittance aggregometry (LTA) after addition of 5 or 20 micromol/L adenosine diphosphate (ADP). Maximal platelet aggregation (Agg(max)) was lower in PS patients after 5 micromol/L ADP (43.6+/-15.7% vs. 48.4+/-12.5%, p=0.096) and 20 micromol/L ADP stimuli (56.2+/-15.6% vs. 61.3+/-11.6%, p=0.073) compared with non-smoking (NS) patients. However, there were no differences in 5 micromol/L (42.6+/-16.3% vs. 43.8+/-15.6%, p=0.776) and 20 micromol/L ADP-induced Agg(max) (54.8+/-14.3% vs. 56.5+/-15.9%, p=0.692) between PS patients <0.5 pack/day and >/=0.5 pack/day. Although more PS patients met the criteria for low post-clopidogrel platelet reactivity (LPPR) (</=37%; the lowest quartile of 5 micromol/L ADP-induced Agg(max)) than NS patients (30.9% vs. 13.5%, p=0.048), advancing age was the only independent predictor of LPPR {odds ratio (OR) 0.960, 95% confidence interval (CI) 0.929 to 0.993, p=0.019}. PS is significantly not associated with decreased residual platelet reactivity in AMI patients.
AbstractList Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined.BACKGROUND AND OBJECTIVESSmoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined.Study cohorts were recruited from a pool of patients at our hospital who were undergoing coronary stenting for AMI (n=134). Immediately after arrival at the emergency room (ER), all patients received a 600 mg loading dose of clopidogrel followed by a maintenance dose of 75 mg/day. Platelet aggregation was measured with light transmittance aggregometry (LTA) after addition of 5 or 20 micromol/L adenosine diphosphate (ADP).SUBJECTS AND METHODSStudy cohorts were recruited from a pool of patients at our hospital who were undergoing coronary stenting for AMI (n=134). Immediately after arrival at the emergency room (ER), all patients received a 600 mg loading dose of clopidogrel followed by a maintenance dose of 75 mg/day. Platelet aggregation was measured with light transmittance aggregometry (LTA) after addition of 5 or 20 micromol/L adenosine diphosphate (ADP).Maximal platelet aggregation (Agg(max)) was lower in PS patients after 5 micromol/L ADP (43.6+/-15.7% vs. 48.4+/-12.5%, p=0.096) and 20 micromol/L ADP stimuli (56.2+/-15.6% vs. 61.3+/-11.6%, p=0.073) compared with non-smoking (NS) patients. However, there were no differences in 5 micromol/L (42.6+/-16.3% vs. 43.8+/-15.6%, p=0.776) and 20 micromol/L ADP-induced Agg(max) (54.8+/-14.3% vs. 56.5+/-15.9%, p=0.692) between PS patients <0.5 pack/day and >/=0.5 pack/day. Although more PS patients met the criteria for low post-clopidogrel platelet reactivity (LPPR) (</=37%; the lowest quartile of 5 micromol/L ADP-induced Agg(max)) than NS patients (30.9% vs. 13.5%, p=0.048), advancing age was the only independent predictor of LPPR {odds ratio (OR) 0.960, 95% confidence interval (CI) 0.929 to 0.993, p=0.019}.RESULTSMaximal platelet aggregation (Agg(max)) was lower in PS patients after 5 micromol/L ADP (43.6+/-15.7% vs. 48.4+/-12.5%, p=0.096) and 20 micromol/L ADP stimuli (56.2+/-15.6% vs. 61.3+/-11.6%, p=0.073) compared with non-smoking (NS) patients. However, there were no differences in 5 micromol/L (42.6+/-16.3% vs. 43.8+/-15.6%, p=0.776) and 20 micromol/L ADP-induced Agg(max) (54.8+/-14.3% vs. 56.5+/-15.9%, p=0.692) between PS patients <0.5 pack/day and >/=0.5 pack/day. Although more PS patients met the criteria for low post-clopidogrel platelet reactivity (LPPR) (</=37%; the lowest quartile of 5 micromol/L ADP-induced Agg(max)) than NS patients (30.9% vs. 13.5%, p=0.048), advancing age was the only independent predictor of LPPR {odds ratio (OR) 0.960, 95% confidence interval (CI) 0.929 to 0.993, p=0.019}.PS is significantly not associated with decreased residual platelet reactivity in AMI patients.CONCLUSIONPS is significantly not associated with decreased residual platelet reactivity in AMI patients.
Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined. Study cohorts were recruited from a pool of patients at our hospital who were undergoing coronary stenting for AMI (n=134). Immediately after arrival at the emergency room (ER), all patients received a 600 mg loading dose of clopidogrel followed by a maintenance dose of 75 mg/day. Platelet aggregation was measured with light transmittance aggregometry (LTA) after addition of 5 or 20 micromol/L adenosine diphosphate (ADP). Maximal platelet aggregation (Agg(max)) was lower in PS patients after 5 micromol/L ADP (43.6+/-15.7% vs. 48.4+/-12.5%, p=0.096) and 20 micromol/L ADP stimuli (56.2+/-15.6% vs. 61.3+/-11.6%, p=0.073) compared with non-smoking (NS) patients. However, there were no differences in 5 micromol/L (42.6+/-16.3% vs. 43.8+/-15.6%, p=0.776) and 20 micromol/L ADP-induced Agg(max) (54.8+/-14.3% vs. 56.5+/-15.9%, p=0.692) between PS patients <0.5 pack/day and >/=0.5 pack/day. Although more PS patients met the criteria for low post-clopidogrel platelet reactivity (LPPR) (</=37%; the lowest quartile of 5 micromol/L ADP-induced Agg(max)) than NS patients (30.9% vs. 13.5%, p=0.048), advancing age was the only independent predictor of LPPR {odds ratio (OR) 0.960, 95% confidence interval (CI) 0.929 to 0.993, p=0.019}. PS is significantly not associated with decreased residual platelet reactivity in AMI patients.
Background and Objectives: Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined. Subjects and Methods: Study cohorts were recruited from a pool of patients at our hospital who were undergoing coronary stenting for AMI (n=134). Immediately after arrival at the emergency room (ER), all patients received a 600mg loading dose of clopidogrel followed by a maintenance dose of 75 mg/day. Platelet aggregation was measured with light transmittance aggregometry (LTA) after addition of 5 or 20 μmol/L adenosine diphosphate (ADP). Results: Maximal platelet aggregation (Aggmax) was lower in PS patients after 5 μmol/L ADP (43.6±15.7% vs. 48.4±12.5%, p=0.096) and 20 μmol/L ADP stimuli (56.2±15.6% vs. 61.3±11.6%, p=0.073) compared with non-smoking (NS) patients. However, there were no differences in 5 μmol/L (42.6±16.3% vs. 43.8±15.6%,p=0.776) and 20 μmol/L ADP-induced Aggmax (54.8±14.3% vs. 56.5±15.9%, p=0.692) between PS patients <0.5 pack/day and ≥0.5 pack/day. Although more PS patients met the criteria for low post-clopidogrel platelet reactivity (LPPR) (≤37%; the lowest quartile of 5 μmol/L ADP-induced Aggmax) than NS patients (30.9% vs. 13.5%, p=0.048), advancing age was the only independent predictor of LPPR {odds ratio (OR) 0.960, 95%confidence interval (CI) 0.929 to 0.993, p=0.019}. Conclusion: PS is significantly not associated with decreased residual platelet reactivity in AMI patients. KCI Citation Count: 1
Author Koh, Jin-Sin
Kwak, Choong Hwan
Kang, Min-Kyung
Hwang, Jin-Yong
Kim, In-Suk
Ahn, Yeon-Jeong
Hwang, Seok-Jae
Jeong, Young-Hoon
Park, Yongwhi
Cho, Jung-Hyun
AuthorAffiliation 1 Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
2 Department of Laboratory Medicine, Gyeongsang National University Hospital, Jinju, Korea
AuthorAffiliation_xml – name: 1 Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
– name: 2 Department of Laboratory Medicine, Gyeongsang National University Hospital, Jinju, Korea
Author_xml – sequence: 1
  givenname: Jung-Hyun
  surname: Cho
  fullname: Cho, Jung-Hyun
  organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
– sequence: 2
  givenname: Young-Hoon
  surname: Jeong
  fullname: Jeong, Young-Hoon
  organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
– sequence: 3
  givenname: Yeon-Jeong
  surname: Ahn
  fullname: Ahn, Yeon-Jeong
  organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
– sequence: 4
  givenname: Min-Kyung
  surname: Kang
  fullname: Kang, Min-Kyung
  organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
– sequence: 5
  givenname: Jin-Sin
  surname: Koh
  fullname: Koh, Jin-Sin
  organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
– sequence: 6
  givenname: In-Suk
  surname: Kim
  fullname: Kim, In-Suk
  organization: Department of Laboratory Medicine, Gyeongsang National University Hospital, Jinju, Korea
– sequence: 7
  givenname: Yongwhi
  surname: Park
  fullname: Park, Yongwhi
  organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
– sequence: 8
  givenname: Seok-Jae
  surname: Hwang
  fullname: Hwang, Seok-Jae
  organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
– sequence: 9
  givenname: Choong Hwan
  surname: Kwak
  fullname: Kwak, Choong Hwan
  organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
– sequence: 10
  givenname: Jin-Yong
  surname: Hwang
  fullname: Hwang, Jin-Yong
  organization: Division of Cardiology, Departments of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20339496$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001431846$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1kV-PEyEUxYlZ4_7RD-CL4c34MBUGZhheTJpG3SZr3Kw1PhKGgZaWgQp0k357abu7WU3k5XLD75yTy70EZz54DcBbjCYUMfRxo9aTGh27CZlgzF-AC8xIVzXlnD3da3QOLlNaI9RSWvNX4LxGhHDK2wuwXqw0nI9bqTIMBv4Yw8b6JQwe3oaUq5kLWzuEZdQO3jqZtdMZ3ulC23ub99AWTmarfU7wl80rOFW7rOG3fVAyDlY6OPdGxoIH_xq8NNIl_eahXoGfXz4vZtfVzfev89n0plKEMl6Rumc9U23PGq7bgRmlGkKMHnQrEcO4UahFTKKBStV0ElFkuhb3piHdoHEvyRX4cPL10YiNsiJIe6zLIDZRTO8Wc4Ex4zWnhf10Yre7ftSDKoNE6cQ22lHG_VH594u3q-JzL-qOUs5YMXj_YBDD751OWYw2Ke2c9DrskmCEdJhwVBfy3fOop4zHXRSAnQAVQ0pRG6FsloefK8nWCYzEYetllLU4bL10gpRJeFHif5SP5v_X_AFhzbF_
CitedBy_id crossref_primary_10_1016_j_ahj_2011_06_005
crossref_primary_10_1007_s11886_013_0361_7
crossref_primary_10_1016_j_jcin_2016_06_042
crossref_primary_10_1007_s10554_011_9964_5
crossref_primary_10_1016_j_ahj_2012_12_024
crossref_primary_10_1080_09537104_2019_1572878
crossref_primary_10_1136_heartjnl_2013_304138
crossref_primary_10_1016_j_jacc_2013_10_043
crossref_primary_10_4070_kcj_2010_40_3_112
Cites_doi 10.1016/j.jacc.2008.12.044
10.1016/j.jacc.2003.12.047
10.1016/j.jacc.2007.01.094
10.4070/kcj.2008.38.3.161
10.1016/j.jacc.2008.12.025
10.1161/CIRCULATIONAHA.106.675934
10.1038/ncpcardio0602
10.2217/14622416.9.9.1251
10.1016/j.jacc.2008.04.045
10.1016/j.jacc.2007.12.056
10.1161/01.CIR.0000130846.46168.03
10.1016/S0090-9556(24)15013-1
10.2165/00003088-199936060-00004
10.1093/eurheartj/ehn313
10.1161/01.CIR.0000047060.60595.CC
10.1016/S0140-6736(06)69249-0
10.1056/NEJMe0810513
10.1161/01.CIR.94.12.3109
10.1016/j.jacc.2007.06.064
10.1111/j.1538-7836.2007.02812.x
10.4070/kcj.2005.35.8.613
10.1161/CIRCULATIONAHA.109.866533
10.1016/j.jacc.2008.07.055
10.1016/S0049-3848(98)00184-4
10.1056/NEJMoa0809171
10.1038/35051599
10.4070/kcj.2007.37.8.373
10.1097/00005344-200210000-00010
ContentType Journal Article
Copyright Copyright © 2010 The Korean Society of Cardiology 2010
Copyright_xml – notice: Copyright © 2010 The Korean Society of Cardiology 2010
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.4070/kcj.2010.40.3.119
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1738-5555
EndPage 124
ExternalDocumentID oai_kci_go_kr_ARTI_1179294
PMC2844977
20339496
10_4070_kcj_2010_40_3_119
Genre Journal Article
GroupedDBID ---
5-W
8JR
8XY
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EF.
F5P
HYE
KQ8
M48
O5R
O5S
OK1
PGMZT
RPM
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c3479-32b7b7c6b759e6d7fcc533fede6a07115c0607a0d4ac58a040f861bf538de1ba3
IEDL.DBID M48
ISSN 1738-5520
1738-5555
IngestDate Sun Mar 09 08:00:04 EDT 2025
Thu Aug 21 18:28:01 EDT 2025
Fri Jul 11 11:46:28 EDT 2025
Wed Apr 02 03:48:17 EDT 2025
Tue Aug 05 11:59:45 EDT 2025
Thu Apr 24 23:07:34 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Acute myocardial infarction
Post-clopidogrel platelet reactivity
Smoking
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3479-32b7b7c6b759e6d7fcc533fede6a07115c0607a0d4ac58a040f861bf538de1ba3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000708.2010.40.3.001
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4070/kcj.2010.40.3.119
PMID 20339496
PQID 733813902
PQPubID 23479
PageCount 6
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1179294
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2844977
proquest_miscellaneous_733813902
pubmed_primary_20339496
crossref_citationtrail_10_4070_kcj_2010_40_3_119
crossref_primary_10_4070_kcj_2010_40_3_119
PublicationCentury 2000
PublicationDate 20100301
PublicationDateYYYYMMDD 2010-03-01
PublicationDate_xml – month: 3
  year: 2010
  text: 20100301
  day: 1
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Korean circulation journal
PublicationTitleAlternate Korean Circ J
PublicationYear 2010
Publisher The Korean Society of Cardiology
대한심장학회
Publisher_xml – name: The Korean Society of Cardiology
– name: 대한심장학회
References Lim (10.4070/kcj.2010.40.3.119_ref19) 2005; 35
Ambrose (10.4070/kcj.2010.40.3.119_ref17) 2004; 43
Jeong (10.4070/kcj.2010.40.3.119_ref11) 2008; 29
Jeong (10.4070/kcj.2010.40.3.119_ref10) 2009; 53
Buonamici (10.4070/kcj.2010.40.3.119_ref8) 2007; 49
Geisler (10.4070/kcj.2010.40.3.119_ref28) 2008; 6
Siller-Matula (10.4070/kcj.2010.40.3.119_ref2) 2008; 52
Freedman (10.4070/kcj.2010.40.3.119_ref26) 2009; 360
Luscher (10.4070/kcj.2010.40.3.119_ref24) 2007; 115
Teo (10.4070/kcj.2010.40.3.119_ref16) 2006; 368
Lau (10.4070/kcj.2010.40.3.119_ref5) 2003; 107
Bliden (10.4070/kcj.2010.40.3.119_ref7) 2008; 52
Iba (10.4070/kcj.2010.40.3.119_ref12) 1999; 27
Cho (10.4070/kcj.2010.40.3.119_ref18) 2008; 38
Ichiki (10.4070/kcj.2010.40.3.119_ref22) 1996; 94
Matetzky (10.4070/kcj.2010.40.3.119_ref9) 2004; 109
Zevin (10.4070/kcj.2010.40.3.119_ref6) 1999; 36
Geisler (10.4070/kcj.2010.40.3.119_ref29) 2008; 9
Desai (10.4070/kcj.2010.40.3.119_ref15) 2009; 53
Berger (10.4070/kcj.2010.40.3.119_ref14) 2009; 120
Fusegawa (10.4070/kcj.2010.40.3.119_ref21) 1999; 93
Mega (10.4070/kcj.2010.40.3.119_ref25) 2009; 360
Hollopeter (10.4070/kcj.2010.40.3.119_ref1) 2001; 409
Sawada (10.4070/kcj.2010.40.3.119_ref23) 2002; 40
Trenk (10.4070/kcj.2010.40.3.119_ref4) 2008; 51
Gilard (10.4070/kcj.2010.40.3.119_ref3) 2008; 51
Cho (10.4070/kcj.2010.40.3.119_ref20) 2007; 37
Tantcheva-Poor (10.4070/kcj.2010.40.3.119_ref13) 1999; 9
Gurbel (10.4070/kcj.2010.40.3.119_ref27) 2006; 3
18781853 - Pharmacogenomics. 2008 Sep;9(9):1251-9
8989117 - Circulation. 1996 Dec 15;94(12):3109-14
10376760 - Pharmacogenetics. 1999 Apr;9(2):131-44
19007592 - J Am Coll Cardiol. 2008 Nov 4;52(19):1557-63
19106084 - N Engl J Med. 2009 Jan 22;360(4):354-62
16920470 - Lancet. 2006 Aug 19;368(9536):647-58
19933933 - Circulation. 2009 Dec 8;120(23):2337-44
18206732 - J Am Coll Cardiol. 2008 Jan 22;51(3):256-60
11196645 - Nature. 2001 Jan 11;409(6817):202-7
19164193 - N Engl J Med. 2009 Jan 22;360(4):411-3
18617479 - Eur Heart J. 2008 Sep;29(17):2186-7; author reply 2187
17572245 - J Am Coll Cardiol. 2007 Jun 19;49(24):2312-7
19358940 - J Am Coll Cardiol. 2009 Apr 14;53(15):1273-8
10093968 - Thromb Res. 1999 Mar 15;93(6):271-8
12515739 - Circulation. 2003 Jan 7;107(1):32-7
15145091 - J Am Coll Cardiol. 2004 May 19;43(10):1731-7
10460794 - Drug Metab Dispos. 1999 Sep;27(9):977-82
19324253 - J Am Coll Cardiol. 2009 Mar 31;53(13):1101-9
10427467 - Clin Pharmacokinet. 1999 Jun;36(6):425-38
18482659 - J Am Coll Cardiol. 2008 May 20;51(20):1925-34
16810174 - Nat Clin Pract Cardiovasc Med. 2006 Jul;3(7):387-95
17325255 - Circulation. 2007 Feb 27;115(8):1051-8
15184279 - Circulation. 2004 Jun 29;109(25):3171-5
12352319 - J Cardiovasc Pharmacol. 2002 Oct;40(4):571-6
17949474 - J Thromb Haemost. 2008 Jan;6(1):54-61
18687246 - J Am Coll Cardiol. 2008 Aug 12;52(7):531-3
References_xml – volume: 53
  start-page: 1273
  year: 2009
  ident: 10.4070/kcj.2010.40.3.119_ref15
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.12.044
– volume: 43
  start-page: 1731
  year: 2004
  ident: 10.4070/kcj.2010.40.3.119_ref17
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2003.12.047
– volume: 49
  start-page: 2312
  year: 2007
  ident: 10.4070/kcj.2010.40.3.119_ref8
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.01.094
– volume: 38
  start-page: 161
  year: 2008
  ident: 10.4070/kcj.2010.40.3.119_ref18
  publication-title: Korean Circ J
  doi: 10.4070/kcj.2008.38.3.161
– volume: 53
  start-page: 1101
  year: 2009
  ident: 10.4070/kcj.2010.40.3.119_ref10
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.12.025
– volume: 115
  start-page: 1051
  year: 2007
  ident: 10.4070/kcj.2010.40.3.119_ref24
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.675934
– volume: 3
  start-page: 387
  year: 2006
  ident: 10.4070/kcj.2010.40.3.119_ref27
  publication-title: Nat Clin Pract Cardiovasc Med
  doi: 10.1038/ncpcardio0602
– volume: 9
  start-page: 1251
  year: 2008
  ident: 10.4070/kcj.2010.40.3.119_ref29
  publication-title: Pharmacogenomics
  doi: 10.2217/14622416.9.9.1251
– volume: 9
  start-page: 131
  year: 1999
  ident: 10.4070/kcj.2010.40.3.119_ref13
  publication-title: Pharmacogenetics
– volume: 52
  start-page: 531
  year: 2008
  ident: 10.4070/kcj.2010.40.3.119_ref7
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.04.045
– volume: 51
  start-page: 1925
  year: 2008
  ident: 10.4070/kcj.2010.40.3.119_ref4
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.12.056
– volume: 109
  start-page: 3171
  year: 2004
  ident: 10.4070/kcj.2010.40.3.119_ref9
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000130846.46168.03
– volume: 27
  start-page: 977
  year: 1999
  ident: 10.4070/kcj.2010.40.3.119_ref12
  publication-title: Drug Metab Dispos
  doi: 10.1016/S0090-9556(24)15013-1
– volume: 36
  start-page: 425
  year: 1999
  ident: 10.4070/kcj.2010.40.3.119_ref6
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-199936060-00004
– volume: 29
  start-page: 2186
  year: 2008
  ident: 10.4070/kcj.2010.40.3.119_ref11
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehn313
– volume: 107
  start-page: 32
  year: 2003
  ident: 10.4070/kcj.2010.40.3.119_ref5
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000047060.60595.CC
– volume: 368
  start-page: 647
  year: 2006
  ident: 10.4070/kcj.2010.40.3.119_ref16
  publication-title: Lancet
  doi: 10.1016/S0140-6736(06)69249-0
– volume: 360
  start-page: 411
  year: 2009
  ident: 10.4070/kcj.2010.40.3.119_ref26
  publication-title: N Engl J Med
  doi: 10.1056/NEJMe0810513
– volume: 94
  start-page: 3109
  year: 1996
  ident: 10.4070/kcj.2010.40.3.119_ref22
  publication-title: Circulation
  doi: 10.1161/01.CIR.94.12.3109
– volume: 51
  start-page: 256
  year: 2008
  ident: 10.4070/kcj.2010.40.3.119_ref3
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.06.064
– volume: 6
  start-page: 54
  year: 2008
  ident: 10.4070/kcj.2010.40.3.119_ref28
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2007.02812.x
– volume: 35
  start-page: 613
  year: 2005
  ident: 10.4070/kcj.2010.40.3.119_ref19
  publication-title: Korean Circ J
  doi: 10.4070/kcj.2005.35.8.613
– volume: 120
  start-page: 2337
  year: 2009
  ident: 10.4070/kcj.2010.40.3.119_ref14
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.866533
– volume: 52
  start-page: 1557
  year: 2008
  ident: 10.4070/kcj.2010.40.3.119_ref2
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.07.055
– volume: 93
  start-page: 271
  year: 1999
  ident: 10.4070/kcj.2010.40.3.119_ref21
  publication-title: Thromb Res
  doi: 10.1016/S0049-3848(98)00184-4
– volume: 360
  start-page: 354
  year: 2009
  ident: 10.4070/kcj.2010.40.3.119_ref25
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0809171
– volume: 409
  start-page: 202
  year: 2001
  ident: 10.4070/kcj.2010.40.3.119_ref1
  publication-title: Nature
  doi: 10.1038/35051599
– volume: 37
  start-page: 373
  year: 2007
  ident: 10.4070/kcj.2010.40.3.119_ref20
  publication-title: Korean Circ J
  doi: 10.4070/kcj.2007.37.8.373
– volume: 40
  start-page: 571
  year: 2002
  ident: 10.4070/kcj.2010.40.3.119_ref23
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/00005344-200210000-00010
– reference: 8989117 - Circulation. 1996 Dec 15;94(12):3109-14
– reference: 16810174 - Nat Clin Pract Cardiovasc Med. 2006 Jul;3(7):387-95
– reference: 18781853 - Pharmacogenomics. 2008 Sep;9(9):1251-9
– reference: 10427467 - Clin Pharmacokinet. 1999 Jun;36(6):425-38
– reference: 19007592 - J Am Coll Cardiol. 2008 Nov 4;52(19):1557-63
– reference: 16920470 - Lancet. 2006 Aug 19;368(9536):647-58
– reference: 17572245 - J Am Coll Cardiol. 2007 Jun 19;49(24):2312-7
– reference: 18617479 - Eur Heart J. 2008 Sep;29(17):2186-7; author reply 2187
– reference: 11196645 - Nature. 2001 Jan 11;409(6817):202-7
– reference: 17949474 - J Thromb Haemost. 2008 Jan;6(1):54-61
– reference: 12352319 - J Cardiovasc Pharmacol. 2002 Oct;40(4):571-6
– reference: 19324253 - J Am Coll Cardiol. 2009 Mar 31;53(13):1101-9
– reference: 19358940 - J Am Coll Cardiol. 2009 Apr 14;53(15):1273-8
– reference: 12515739 - Circulation. 2003 Jan 7;107(1):32-7
– reference: 19164193 - N Engl J Med. 2009 Jan 22;360(4):411-3
– reference: 10376760 - Pharmacogenetics. 1999 Apr;9(2):131-44
– reference: 19106084 - N Engl J Med. 2009 Jan 22;360(4):354-62
– reference: 17325255 - Circulation. 2007 Feb 27;115(8):1051-8
– reference: 18482659 - J Am Coll Cardiol. 2008 May 20;51(20):1925-34
– reference: 15145091 - J Am Coll Cardiol. 2004 May 19;43(10):1731-7
– reference: 10093968 - Thromb Res. 1999 Mar 15;93(6):271-8
– reference: 18687246 - J Am Coll Cardiol. 2008 Aug 12;52(7):531-3
– reference: 19933933 - Circulation. 2009 Dec 8;120(23):2337-44
– reference: 18206732 - J Am Coll Cardiol. 2008 Jan 22;51(3):256-60
– reference: 10460794 - Drug Metab Dispos. 1999 Sep;27(9):977-82
– reference: 15184279 - Circulation. 2004 Jun 29;109(25):3171-5
SSID ssj0064429
Score 1.8288299
Snippet Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between...
Background and Objectives: Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However,...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 119
SubjectTerms Original
내과학
Title The Impact of Smoking on Post-Clopidogrel Platelet Reactivity in Patients With Acute Myocardial Infarction
URI https://www.ncbi.nlm.nih.gov/pubmed/20339496
https://www.proquest.com/docview/733813902
https://pubmed.ncbi.nlm.nih.gov/PMC2844977
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001431846
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Korean Circulation Journal, 2010, 40(3), , pp.119-124
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1738-5555
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064429
  issn: 1738-5520
  databaseCode: KQ8
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1738-5555
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064429
  issn: 1738-5520
  databaseCode: DIK
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 1738-5555
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064429
  issn: 1738-5520
  databaseCode: 5-W
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1738-5555
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064429
  issn: 1738-5520
  databaseCode: RPM
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1738-5555
  dateEnd: 20250331
  omitProxy: true
  ssIdentifier: ssj0064429
  issn: 1738-5520
  databaseCode: M48
  dateStart: 20090301
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA93J4gv4rf1iyA-CT3T5rNPchwet8KKqIv3FpI08fautnf7Ad5_78y2u7iyCD6VtGlD85vp_KbJzBDyhofEvY4sdxXzufBlnRtTuFw6XxlugpAag5PHn9TpRHw8k2d7ZF3eapjA-U7XDutJTWbN4a_rm_eg8MBfD8EdYe8uw0W_R0uACwrfgGqf3ALDVKKQj8VmUQEs_6poWaFBx6Ush0XO3Y_YMlP77SztYqB_b6T8wzKd3CN3B0pJj3oZuE_2YvuA3B4Pi-YPyQWIAh2toiFpl-jXnx3-HqddS7FSb36MMVN1B353Qz83QD0BSfolYsAD1pWgU-jXJ1-d0-_TxTk9CstFpOMbsIIoXQ0dtQnUBRF-RCYnH74dn-ZDiYU8YAhpzkuvvQ7Ka1lFVesUAvC_FOuoHJCPQgammHasFi5I40Djk1GFT_CZrGPhHX9MDtqujU8JDbEyypgoa-BoWihoOCAHiicsHZ5SRth6Rm0Y8o9jGYzGgh-CIFgAwSII0LIcXJMqI283t1z1yTf-1fk1wATnpxZTZuPxR2cvZxYcgxHmNAciKDJC1yha0CNcHHFt7JZzq8FXBzbMyow86UHdDFkyzitRqYzoLbg3HXC87Svt9HyVqhuMvwCG_ex_XuQ5udNvUcCNbi_IwWK2jC-B-Sz8q5U8_wZzaf9T
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Impact+of+Smoking+on+Post-Clopidogrel+Platelet+Reactivity+in+Patients+With+Acute+Myocardial+Infarction&rft.jtitle=Korean+circulation+journal&rft.au=Cho%2C+Jung-Hyun&rft.au=Jeong%2C+Young-Hoon&rft.au=Ahn%2C+Yeon-Jeong&rft.au=Kang%2C+Min-Kyung&rft.date=2010-03-01&rft.issn=1738-5520&rft.volume=40&rft.issue=3&rft.spage=119&rft_id=info:doi/10.4070%2Fkcj.2010.40.3.119&rft.externalDBID=n%2Fa&rft.externalDocID=10_4070_kcj_2010_40_3_119
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-5520&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-5520&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-5520&client=summon